Form 8-K CORE LABORATORIES N V For: Jul 20

Go back to Form 8-K CORE LABORATORIES N V For: Jul 20

Core Laboratories (CLB) Reports In-Line Q2 EPS, Offers Q4 Guidance

July 20, 2016 4:16 PM EDT

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $148.1 million versus the consensus estimate of $146.4 million.

GUIDANCE:

Core Laboratories sees Q3 2016 EPS of $0.39-$0.41, versus the consensus of $0.41.... More